Plasma CXCL13 is a predictive factor for HBsAg loss and clinical relapse after discontinuation of nucleos(t)ide analogue treatmentObservational Study Published on 2019-01-012023-06-18 Journal: Clinical immunology (Orlando, Fla.) [Category] B형 간염, [키워드] Clinical relapse CXCL13 Discontinuation HBsAg loss Nucleos(t)ide analogue [DOI] 10.1016/j.clim.2018.11.016 [Article Type] Observational Study
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisRandomized Controlled Trial Published on 2018-12-012023-06-19 Journal: Digestive diseases and sciences [Category] B형 간염, [키워드] Chronic Hepatitis B HBsAg loss HBsAg seroconversion virological response [DOI] 10.1007/s10620-018-5251-9 PMC 바로가기 [Article Type] Randomized Controlled Trial
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BClinical Trial Published on 2018-10-012023-06-19 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] antiviral therapy flare HBsAg loss HBV [DOI] 10.1111/liv.13716 [Article Type] Clinical Trial
Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapyArticle Published on 2018-04-012023-06-19 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] Chronic Hepatitis B group-based trajectory models HBsAg loss hepatitis B surface antigen Nucleos(t)ide analogue [DOI] 10.1111/liv.13564
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patientsArticle Published on 2018-03-012023-06-19 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] genotype D. HBeAg-negative CHB HBsAg loss HBV IFNL4 polymorphisms IL28B [DOI] 10.1111/liv.13526
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE studyRandomized Controlled Trial Published on 2017-11-012023-06-18 Journal: Journal of hepatology [Category] B형 간염, [키워드] Finite therapy HBeAg-negative HBsAg loss tenofovir disoproxil fumarate [DOI] 10.1016/j.jhep.2017.07.012 [Article Type] Randomized Controlled Trial
The role of peginterferon in nucleos(t)ide-analogue-treated chronic hepatitis B patients: A review of published literatureReview Published on 2017-08-012023-06-19 Journal: Journal of viral hepatitis [Category] B형 간염, [키워드] Chronic Hepatitis B HBsAg loss Nucleos(t)ide analogue peginterferon [DOI] 10.1111/jvh.12695 [Article Type] Review
The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a TreatmentArticle Published on 2017-03-012023-06-19 Journal: Biomedical and environmental sciences : BES [Category] B형 간염, [키워드] Chronic Hepatitis B HBeAg HBsAg loss Pegylated interferon alpha-2a. [DOI] 10.3967/bes2017.025
HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomesArticle Published on 2016-09-012023-06-16 Journal: Hepatology international [Category] B형 간염, [키워드] Baseline HBsAg level HBsAg loss Hepatocellular carcinoma Seroconversion [DOI] 10.1007/s12072-016-9709-6
Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapyArticle Published on 2016-03-012023-06-18 Journal: Journal of hepatology [Category] B형 간염, [키워드] Adaptive immunity combination therapy HBsAg loss HBV-specific T cells hepatitis B [DOI] 10.1016/j.jhep.2015.10.013